Blagosklonny, M. V., Robey, R., Bates, S., & Fojo, T. (2000). Pretreatment with DNA-damaging agents permits selective killing of checkpoint-deficient cells by microtubule-active drugs. American Society for Clinical Investigation.
Chicago ZitierstilBlagosklonny, Mikhail V., Robert Robey, Susan Bates, und Tito Fojo. Pretreatment With DNA-damaging Agents Permits Selective Killing of Checkpoint-deficient Cells By Microtubule-active Drugs. American Society for Clinical Investigation, 2000.
MLA ZitierstilBlagosklonny, Mikhail V., Robert Robey, Susan Bates, und Tito Fojo. Pretreatment With DNA-damaging Agents Permits Selective Killing of Checkpoint-deficient Cells By Microtubule-active Drugs. American Society for Clinical Investigation, 2000.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.